Overview

This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in the community setting. Participants will gain valuable insights on how healthcare providers can support caregivers in identifying signs of agitated behaviors. The program will also provide an overview of the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease.

SPONSORED BY

Otsuka America Pharmaceutical, Inc.